Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy
Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors––those that respond to immunotherapy––by awakening and enlisting the body's own …
Home »
Immunotherapy drug can beat back early-stage lung cancer
An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage …
FDA Approves Frontline Immunotherapy for Gastric Cancers
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Combo Shows ‘Impressive’ Survival Results in First-Line RCC
The combination of lenvatinib and pembrolizumab outperforms sunitinib as first-line therapy for advanced clear-cell renal cell carcinoma (RCC), based on …
Guillain-Barré Syndrome Treatment
Guillain-Barré syndrome, an autoimmune condition that can result in rapid and severe muscle weakness in a patient, can affect people …
Drug treatment could improve effectiveness of immunotherapy for cancer patients
While immunotherapy—a form of treatment that uses the body’s immune system to recognize, attack and kill tumor cells—has given hope …
Immunotherapy for triple-negative breast cancer approved for NHS in England
The National Institute for Health and Care Excellence (NICE) has approved a new immunotherapy treatment option for some adults with …
Kidney cancer immunotherapy combo approved for NHS use in England
A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the …
Allergy: immune therapy daily peanuts to eat
Encouraging results of a multi-year observational study for all who suffer from a peanut Allergy Who eats a immune therapy …
Combination treatment, diabetes drug and immunotherapy, may help to fight breast cancer
Researchers in Finland have discovered a drug combination that collaborates with the cancer cell oncoprotein MYC, which, in large quantities, …